Inulin increases the beneficial effects of rhubarb supplementation on high-fat high-sugar diet-induced metabolic disorders in mice: impact on energy expenditure, brown adipose tissue activity, and microbiota

References

• NCD Risk factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627–19. doi:10.1016/S0140-6736(17)32129-3.
   PubMed Web of Science ®Google Scholar
• OECD. Organisation for economic co-operation and development. Obesity update 2017. 2017.
   Google Scholar
• The GBD 2015 Obesity collaborators. Health effects of overweight and obesity in 195 Countries over 25 Years. NEJM. 2017;377(1):13–27. doi:10.1056/NEJMoa1614362.
   PubMed Web of Science ®Google Scholar
• Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol. 2002;40(5):937–943. doi:10.1016/S0735-1097(02)02051-X.
   PubMed Web of Science ®Google Scholar
• NCD risk factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–1396. doi:10.1016/S0140-6736(16)30054-X.
   PubMed Web of Science ®Google Scholar
• Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001;104(4):531–543. doi:10.1016/S0092-8674(01)00240-9.
   PubMed Web of Science ®Google Scholar
• Schwartz MW, Seeley RJ, Zeltser LM, Drewnowski A, Ravussin E, Redman LM, Leibel RL. Obesity pathogenesis: an endocrine society scientific statement. Endocr Rev. 2017;38(4):267–296. doi:10.1210/er.2017-00111.
   PubMed Web of Science ®Google Scholar
• Reilly SM, Saltiel AR. Adapting to obesity with adipose tissue inflammation. Nat Rev Endocrinol. 2017;13(11):633–643. doi:10.1038/nrendo.2017.90.
   PubMed Web of Science ®Google Scholar
• Rutkowski JM, Stern JH, Scherer PE. The cell biology of fat expansion. J Cell Biol. 2015;208(5):501–512. doi:10.1083/jcb.201409063.
   PubMed Web of Science ®Google Scholar
• Richard D, Picard F. Brown fat biology and thermogenesis. Front Biosci. 2011;16:1233–1260. doi:10.2741/3786.
   PubMed Web of Science ®Google Scholar
• Smith RE, Horwitz BA. Brown fat and thermogenesis. Physiol Rev. 1969;49(2):330–425. doi:10.1152/physrev.1969.49.2.330.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993;259(5091):87–91. doi:10.1126/science.7678183.
   PubMed Web of Science ®Google Scholar
• Cani PD. Changes in gut microflora are responsible for high-fat diet-induced diabetes through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:S68–S68. doi:10.1007/s00125-007-0791-0.
   PubMed Web of Science ®Google Scholar
• Xu H, Bornes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112(12):1821–1830. doi:10.1172/JCI200319451.
   PubMed Web of Science ®Google Scholar
• Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest. 2000;106(2):171–176. doi:10.1172/JCI10583.
   PubMed Web of Science ®Google Scholar
• Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov. 2008;7(8):678–693. doi:10.1038/nrd2619.
   PubMed Web of Science ®Google Scholar
• Tan J, McKenzie C, Potamitis M, Thorburn AN, Mackay CR, Macia L. The role of short-chain fatty acids in health and disease. Adv Immunol. 2014;121:91–119.
   PubMed Web of Science ®Google Scholar
• Agus A, Planchais J, Sokol H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe. 2018;23(6):716–724. doi:10.1016/j.chom.2018.05.003.
   PubMed Web of Science ®Google Scholar
• Bhat MI, Kapila R. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals. Nutr Rev. 2017;75(5):374–389. doi:10.1093/nutrit/nux001.
   PubMed Web of Science ®Google Scholar
• Matsumoto M. Impact of intestinal microbiota on intestinal luminal metabolome. Sci Rep. 2012;2(1):233. doi:10.1038/srep00233.
   PubMedGoogle Scholar
• Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J. 2003;376(Pt 1):1–14. doi:10.1042/bj20031327.
   PubMed Web of Science ®Google Scholar
• Heaver SL, Johnson EL, Ley RE. Sphingolipids in host-microbial interactions. Curr Opin Microbiol. 2018;43:92–99. doi:10.1016/j.mib.2017.12.011.
   PubMed Web of Science ®Google Scholar
• Li Z, Yi C-X, Katiraei S, Kooijman S, Zhou E, Chung CK, Gao Y, van den Heuvel JK, Meijer OC, Berbée JFP, et al. Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit. Gut. 2018;67(7):1269–1279. doi:10.1136/gutjnl-2017-314050.
   PubMed Web of Science ®Google Scholar
• Mollica MP, Mattace Raso G, Cavaliere G, Trinchese G, De Filippo C, Aceto S, Prisco M, Pirozzi C, Di Guida F, Lama A, et al. Butyrate regulates liver mitochondrial function, efficiency, and dynamics in insulin-resistant obese mice. Diabetes. 2017;66(5):1405–1418. doi:10.2337/db16-0924.
   PubMed Web of Science ®Google Scholar
• De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F, Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156(1–2):84–96. doi:10.1016/j.cell.2013.12.016.
   PubMed Web of Science ®Google Scholar
• Régnier M, Van Hul M, Knauf C, Cani PD. Gut microbiome, endocrine control of gut barrier function and metabolic diseases. J Endocrinol. 2021;248(2):R67–r82. doi:10.1530/JOE-20-0473.
   PubMed Web of Science ®Google Scholar
• Reid G, Gadir A, Dhir R, Li C, Luk A, Zhao G, Fung K, Ip M. Probiotics: reiterating what they are and what they are not. Front Microbiol. 2019;10:10. doi:10.3389/fmicb.2019.00010.
   PubMed Web of Science ®Google Scholar
• Sanders M, Morenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019;16:605–616.
   PubMed Web of Science ®Google Scholar
• Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018;23(6):705–715. doi:10.1016/j.chom.2018.05.012.
   PubMed Web of Science ®Google Scholar
• Van Hul M, Cani PD. Targeting carbohydrates and polyphenols for a healthy microbiome and healthy weight. Curr Nutr Rep. 2019;8(4):307–316. doi:10.1007/s13668-019-00281-5.
   PubMedGoogle Scholar
• Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, Scott K, Stanton C, Swanson KS, Cani PD, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491–502. doi:10.1038/nrgastro.2017.75.
   PubMed Web of Science ®Google Scholar
• Cani P, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of glucose tolerance and hepatic insulin sensitivity by oligofructose requires a functional glucagon-like peptide 1 receptor. Diabetes. 2006;55:1484–1490.
   PubMed Web of Science ®Google Scholar
• Everard A, Lazarevic V, Gaïa N, Johansson M, Ståhlman M, Backhed F, Delzenne NM, Schrenzel J, François P, Cani PD, et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. The ISME Journal. 2014;8(10):2116–2130. doi:10.1038/ismej.2014.45.
   PubMed Web of Science ®Google Scholar
• Cani PD, Knauf C, Iglesias MA, Drucker DJ, Delzenne NM, Burcelin R. Improvement of Glucose Tolerance and Hepatic Insulin Sensitivity by Oligofructose Requires a Functional Glucagon-Like Peptide 1 Receptor. Diabetes. 2006;55(5):1484–1490. doi:10.2337/db05-1360.
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR, Delzenne NM. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374–2383.
   PubMed Web of Science ®Google Scholar
• Cani PD, Neyrinck AM, Maton N, Delzenne NM. Oligofructose promotes satiety in rats fed a high-fat diet: involvement of glucagon-like Peptide-1. Obes Res. 2005;13(6):1000–1007. doi:10.1038/oby.2005.117.
   PubMedGoogle Scholar
• Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58(8):1091–1103. doi:10.1136/gut.2008.165886.
   PubMed Web of Science ®Google Scholar
• Delzenne NM, Neyrinck AM, Bäckhed F, Cani PD. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7(11):639–646. doi:10.1038/nrendo.2011.126.
   PubMed Web of Science ®Google Scholar
• Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Neyrinck AM, Possemiers S, Van Holle A, François P, de Vos WM, et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. diabetes. 2011;60(11):2775–2786. doi:10.2337/db11-0227.
   PubMed Web of Science ®Google Scholar
• Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 2009;89(6):1751–1759. doi:10.3945/ajcn.2009.27465.
   PubMed Web of Science ®Google Scholar
• Régnier M, Rastelli M, Morissette A, Suriano F, Le Roy T, Pilon G, Delzenne NM, Marette A, Van Hul M, Cani PD. Rhubarb Supplementation Prevents Diet-Induced Obesity and Diabetes in Association with Increased Akkermansia muciniphila in Mice. Nutrients. 2020;12:10.
   Web of Science ®Google Scholar
• Silveira JP, Seito LN, Eberlin S, Dieamant GC, Nogueira C, Pereda MC, Di Stasi LC. Photoprotective and antioxidant effects of Rhubarb: inhibitory action on tyrosinase and tyrosine kinase activities and TNF-α, IL-1α and α-MSH production in human melanocytes. BMC Complement Altern Med. 2013;13(1):49. doi:10.1186/1472-6882-13-49.
   PubMedGoogle Scholar
• Shia C-S, Juang S-H, Tsai S-Y, Chang P-H, Kuo S-C, Hou Y-C, Chao P-D. Metabolism and Pharmacokinetics of Anthraquinones in Rheum palmatum in Rats and ex vivo Antioxidant Activity. Planta Med. 2009;75(13):1386–1392. doi:10.1055/s-0029-1185725.
   PubMed Web of Science ®Google Scholar
• Raudsepp P, Anton D, Roasto M, Meremäe K, Pedastsaar P, Mäesaar M, Raal A, Laikoja K, Püssa T. The antioxidative and antimicrobial properties of the blue honeysuckle (Lonicera caerulea L.), Siberian rhubarb (Rheum rhaponticum L.) and some other plants, compared to ascorbic acid and sodium nitrite. Food Control. 2013;31(1):129–135. doi:10.1016/j.foodcont.2012.10.007.
   Web of Science ®Google Scholar
• Öztürk M, Aydoğmuş-Öztürk F, Duru ME, Topçu G. Antioxidant activity of stem and root extracts of Rhubarb (Rheum ribes): an edible medicinal plant. Food Chem. 2007;103(2):623–630. doi:10.1016/j.foodchem.2006.09.005.
   Web of Science ®Google Scholar
• Matsuda H, Morikawa T, Toguchida I, Park J-Y, Harima S, Yoshikawa M. Antioxidant constituents from rhubarb: structural requirements of stilbenes for the activity and structures of two new anthraquinone glucosides. Bioorg Med Chem. 2001;9(1):41–50. doi:10.1016/S0968-0896(00)00215-7.
   PubMed Web of Science ®Google Scholar
• Matsuda H, Tomohiro N, Hiraba K, HARIMA S, KO S, Matsuo K, YOSHIKAWA M, Kubo M. Study on Anti-Oketsu Activity of Rhubarb. II. Anti-allergic Effects of Stilbene Components from Rhei undulati Rhizoma (Dried Rhizome of Rheum undulatum Cultivated in Korea). Biol Pharm Bull. 2001;24(3):264–267. doi:10.1248/bpb.24.264.
   PubMed Web of Science ®Google Scholar
• Hu B. Aloe-emodin from rhubarb (Rheum rhabarbarum) inhibits lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol. 2014;153(3):846–853. doi:10.1016/j.jep.2014.03.059.
   PubMed Web of Science ®Google Scholar
• He Z-H, Zhou R, He M-F, Lau CBS, Yue GGL, Ge W, But PPH. Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine. 2011;18(6):470–478. doi:10.1016/j.phymed.2010.10.006.
   PubMed Web of Science ®Google Scholar
• Zhao YL, Wang J-B, Zhou G-D, Shan L-M, Xiao X-H. Investigations of free anthraquinones from rhubarb against alpha-naphthylisothiocyanate-induced cholestatic liver injury in rats. Basic Clin Pharmacol Toxicol. 2009;104(6):463–469. doi:10.1111/j.1742-7843.2009.00389.x.
   PubMed Web of Science ®Google Scholar
• Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232–2243. doi:10.1136/gutjnl-2020-322260.
   PubMed Web of Science ®Google Scholar
• Dehghan P, Gargari BP, Jafar-Abadi MA, Aliasgharzadeh A. Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomized-controlled clinical trial. Int J Food Sci Nutr. 2014;65(1):117–123. doi:10.3109/09637486.2013.836738.
   PubMed Web of Science ®Google Scholar
• Hume MP, Nicolucci AC, Reimer RA. Prebiotic supplementation improves appetite control in children with overweight and obesity: a randomized controlled trial. Am J Clin Nutr. 2017;105(4):790–799. doi:10.3945/ajcn.116.140947.
   PubMed Web of Science ®Google Scholar
• Nicolucci AC, Hume MP, Martínez I, Mayengbam S, Walter J, Reimer RA. Prebiotics reduce body fat and alter intestinal microbiota in children who Are overweight or with obesity. Gastroenterology. 2017;153(3):711–722. doi:10.1053/j.gastro.2017.05.055.
   PubMed Web of Science ®Google Scholar
• Cerdó T, García-Santos J, G. Bermúdez M, Campoy C. The role of probiotics and prebiotics in the prevention and treatment of obesity. Nutrients. 2019;11(3):635. doi:10.3390/nu11030635.
   PubMed Web of Science ®Google Scholar
• Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PG, Neyrinck AM, Bindels LB, de Vos WM, Gibson GR, Thissen J-P, et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut. 2013;62(8):1112–1121. doi:10.1136/gutjnl-2012-303304.
   PubMed Web of Science ®Google Scholar
• Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016;165(6):1332–1345. doi:10.1016/j.cell.2016.05.041.
   PubMed Web of Science ®Google Scholar
• Lee W, Yoon G, Hwang Y-R, Kim Y-K, Kim S-N. Anti-obesity and hypolipidemic effects of Rheum undulatum in high-fat diet-fed C57BL/6 mice through protein tyrosine phosphatase 1B inhibition. BMB Rep. 2012 Mar;45(3):141–146. doi:10.5483/BMBRep.2012.45.3.141.
   PubMed Web of Science ®Google Scholar
• Yang M, Li X, Zeng X, Ou Z, Xue M, Gao D, Liu S, Li X, Yang S. Rheum palmatum L. Attenuates High Fat Diet-Induced Hepatosteatosis by Activating AMP-Activated Protein Kinase. Am J Chin Med. 2016;44(3):551–564. doi:10.1142/S0192415X16500300.
   PubMed Web of Science ®Google Scholar
• Jakab J, Miškić B, Mikšić Š, Juranić B, Ćosić V, Schwarz D, Včev A. Adipogenesis as a Potential Anti-Obesity Target: a Review of Pharmacological Treatment and Natural Products. Diabetes Metab Syndr Obes. 2021;14(14):67–83. doi:10.2147/DMSO.S281186.
   PubMedGoogle Scholar
• Chang E, Kim CY, Products N. Obesity: a Focus on the Regulation of Mitotic Clonal Expansion during Adipogenesis. Molecules. 2019;24(6):1157. doi:10.3390/molecules24061157.
   PubMed Web of Science ®Google Scholar
• Cardona F, Andrés-Lacueva C, Tulipani S, Tinahones FJ, Queipo-Ortuño MI. Benefits of polyphenols on gut microbiota and implications in human health. J Nutr Biochem. 2013;24(8):1415–1422. doi:10.1016/j.jnutbio.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Koppel N, Maini Rekdal V, Balskus EP. Chemical transformation of xenobiotics by the human gut microbiota. Science. 2017;356(6344). doi:10.1126/science.aag2770.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Wu JHY. Flavonoids, dairy foods, and cardiovascular and metabolic health: a review of emerging biologic pathways. Circ Res. 2018;122(2):369–384. doi:10.1161/CIRCRESAHA.117.309008.
   PubMed Web of Science ®Google Scholar
• Nyström EEL, Birchenough GMH, van der Post S, Arike L, Gruber AD, Hansson GC, Johansson MEV. Calcium-activated chloride channel regulator 1 (CLCA1) controls mucus expansion in colon by proteolytic activity. EBioMedicine. 2018;33:134–143. doi:10.1016/j.ebiom.2018.05.031.
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Birchenough GMH, Pradhan M, Nyström EEL, Henricsson M, Hansson GC, Bäckhed F. Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice. J Biol Chem. 2020;295(46):15712–15726. doi:10.1074/jbc.RA120.015771.
   PubMed Web of Science ®Google Scholar
• Schroeder BO, Bäckhed F. Signals from the gut microbiota to distant organs in physiology and disease. Nat Med. 2016;22(10):1079–1089. doi:10.1038/nm.4185.
   PubMed Web of Science ®Google Scholar
• Vernocchi P, Del Chierico F, Putignani L. Gut microbiota profiling: metabolomics based approach to unravel compounds affecting human health. Front Microbiol. 2016;7:1144. doi:10.3389/fmicb.2016.01144.
   PubMed Web of Science ®Google Scholar
• Pathak P, Xie C, Nichols RG, Ferrell JM, Boehme S, Krausz KW, Patterson AD, Gonzalez FJ, Chiang JYL. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 2018;68(4):1574–1588. doi:10.1002/hep.29857.
   PubMed Web of Science ®Google Scholar
• Trabelsi M-S, Daoudi M, Prawitt J, Ducastel S, Touche V, Sayin SI, Perino A, Brighton CA, Sebti Y, Kluza J, et al. Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells. Nat Commun. 2015;6(1):7629. doi:10.1038/ncomms8629.
   PubMedGoogle Scholar
• Katsuma S, Hirasawa A, Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun. 2005;329(1):386–390. doi:10.1016/j.bbrc.2005.01.139.
   PubMed Web of Science ®Google Scholar
• Chambers E, Byrne CS, Aspey K, Chen Y, Khan S, Morrison DJ, Frost G. Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans. Diabetes Obes Metab. 2018;20(4):1034–1039. doi:10.1111/dom.13159.
   PubMed Web of Science ®Google Scholar
• Canfora E, van der Beek CM, Jocken JWE, Goossens GH, Holst JJ, Olde Damink SWM, Lenaerts K, Dejong CHC, Blaak EE. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial. Sci Rep. 2017;7(1):2360. doi:10.1038/s41598-017-02546-x.
   PubMedGoogle Scholar
• den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, Oosterveer MH, Jonker JW, Groen AK, Reijngoud D-J, et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64(7):2398–2408. doi:10.2337/db14-1213.
   PubMed Web of Science ®Google Scholar
• Hattori M, Kondo T, Kishi M, Yamagami K. A single oral administration of acetic acid increased energy expenditure in C57BL/6J mice. Biosci Biotechnol Biochem. 2010;74(10):2158–2159. doi:10.1271/bbb.100486.
   PubMed Web of Science ®Google Scholar
• Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58(7):1509–1517. doi:10.2337/db08-1637.
   PubMed Web of Science ®Google Scholar
• Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4(1):1829. doi:10.1038/ncomms2852.
   PubMed Web of Science ®Google Scholar
• Bartelt A, Bruns OT, Reimer R, Hohenberg H, Ittrich H, Peldschus K, Kaul MG, Tromsdorf UI, Weller H, Waurisch C, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med. 2011;17(2):200–205. doi:10.1038/nm.2297.
   PubMed Web of Science ®Google Scholar
• Wu Q, Kazantzis M, Doege H, Ortegon AM, Tsang B, Falcon A, Stahl A. Fatty acid transport protein 1 is required for nonshivering thermogenesis in brown adipose tissue. Diabetes. 2006;55(12):3229–3237. doi:10.2337/db06-0749.
   PubMed Web of Science ®Google Scholar
• Salazar N, Dewulf EM, Neyrinck AM, Bindels LB, Cani PD, Mahillon J, de Vos WM, Thissen J-P, Gueimonde M, de Los Reyes-Gavilán CG, et al. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin Nutrition. 2015;34(3):501–507. doi:10.1016/j.clnu.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Holle AV, Muccioli GG, Deldicque L, Bindels LB, Pachikian BD, Sohet FM, et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem. 2011;22(8):712–722. doi:10.1016/j.jnutbio.2010.05.009.
   PubMed Web of Science ®Google Scholar
• Chassaing B, Miles-Brown J, Pellizzon M, Ulman E, Ricci M, Zhang L, Patterson AD, Vijay-Kumar M, Gewirtz AT. Lack of soluble fiber drives diet-induced adiposity in mice. Am J Physiol Gastrointest Liver Physiol. 2015;309(7):G528–41. doi:10.1152/ajpgi.00172.2015.
   PubMed Web of Science ®Google Scholar
• Zou J, Chassaing B, Singh V, Pellizzon M, Ricci M, Fythe MD, Kumar MV, Gewirtz AT. Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring IL-22-mediated colonic health. Cell Host Microbe. 2018 e4;23(1):41–53. doi:10.1016/j.chom.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Tan S, Caparros-Martin JA, Matthews VB, Koch H, O’Gara F, Croft KD, Ward NC. Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet. Sci Rep. 2018;8(1):10100. doi:10.1038/s41598-018-28521-8.
   PubMedGoogle Scholar
• Miles JP, Zou J, Kumar M-V, Pellizzon M, Ulman E, Ricci M, Gewirtz AT, Chassaing B. Supplementation of low- and high-fat diets with fermentable fiber exacerbates severity of DSS-induced acute colitis. Inflamm Bowel Dis. 2017;23(7):1133–1143. doi:10.1097/MIB.0000000000001155.
   PubMed Web of Science ®Google Scholar
• Catry E, Bindels LB, Tailleux A, Lestavel S, Neyrinck AM, Goossens J-F, Lobysheva I, Plovier H, Essaghir A, Demoulin J-B, et al. Targeting the gut microbiota with inulin-type fructans: preclinical demonstration of a novel approach in the management of endothelial dysfunction. Gut. 2018 Feb;67(2):271–283. doi:10.1136/gutjnl-2016-313316.
   PubMed Web of Science ®Google Scholar
• Hoving LR, Katiraei S, Pronk A, Heijink M, Vonk KKD, Amghar-el Bouazzaoui F, Vermeulen R, Drinkwaard L, Giera M, van Harmelen V, et al. The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden.CETP mice. Sci Rep. 2018;8(1):16515. doi:10.1038/s41598-018-34970-y.
   PubMedGoogle Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497–509. doi:10.1016/S0021-9258(18)64849-5.
   PubMed Web of Science ®Google Scholar
• Paone P, Suriano F, Jian C, Korpela K, Delzenne NM, Van Hul M, Salonen A, Cani PD. Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion. Gut Microbes. 2022;14(1):2152307. doi:10.1080/19490976.2022.2152307.
   PubMed Web of Science ®Google Scholar
• Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 2005;15(10):1451–1455. doi:10.1101/gr.4086505.
   PubMed Web of Science ®Google Scholar
• Mahé F, Rognes T, Quince C, de Vargas C, Dunthorn M. Swarm: robust and fast clustering method for amplicon-based studies. PeerJ. 2014;2:e593. doi:10.7717/peerj.593.
   PubMed Web of Science ®Google Scholar
• Suriano F, Vieira-Silva S, Falony G, Roumain M, Paquot A, Pelicaen R, Régnier M, Delzenne NM, Raes J, Muccioli GG, et al. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin. Microbiome. 2021;9(1):147. doi:10.1186/s40168-021-01097-8.
   PubMed Web of Science ®Google Scholar